Reported Aug 21, 2019 · Terminated
REMICADE 680 MG QS 250 ML 0.9% NACL IVPB; REMICADE 270 MG QS 250 ML 0.9% NACL IV; REMICADE 730 MG QS 250 ML 0.9% NACL…
Infusion Options, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Infusion Options, Inc. · 5924 13th Ave · Brooklyn, NY · 11219-4934
Is this the product you have?
7 of 7 products
| # | Product as published |
|---|---|
| 1 | REMICADE 680 MG QS 250 ML 0.9% NACL IVPB |
| 2 | REMICADE 270 MG QS 250 ML 0.9% NACL IV |
| 3 | REMICADE 730 MG QS 250 ML 0.9% NACL IVPB REMICADE 330 MG QS 250 ML 0.9% NACL IVPB |
| 4 | REMICADE 740 MG IN 250 ML NS IVPB |
| 5 | REMICADE 650 MG / 250 ml 0.9% NACL |
| 6 | REMICADE 1200 MG/250 ml 0.9% NACL IVPB |
| 7 | REMICADE 800 MG/250 ml 0.9% NACL IVPB REMICADE 600 MG / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233 |
- Lot codes and dates
- All lots within expiry
- Amount recalled
- N/A
This recall covers 76 products
The agency filed one notice per product. You are reading one of them; the other 75 are below.
63 more are in the archive.
Where it was sold
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Infusion Options, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.